STATE OF NEW YORK
________________________________________________________________________
7246--B
2019-2020 Regular Sessions
IN ASSEMBLY
April 18, 2019
___________
Introduced by M. of A. L. ROSENTHAL, QUART, RICHARDSON, CARROLL, WEPRIN
-- read once and referred to the Committee on Health -- committee
discharged, bill amended, ordered reprinted as amended and recommitted
to said committee -- reported and referred to the Committee on Ways
and Means -- committee discharged, bill amended, ordered reprinted as
amended and recommitted to said committee
AN ACT to amend the social services law and the public health law, in
relation to medication for the treatment of substance use disorders
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subdivision 2 of section 365-a of the social services law
2 is amended by adding a new paragraph (gg) to read as follows:
3 (gg) all buprenorphine products, methadone or long acting injectable
4 naltrexone for detoxification or maintenance treatment of a substance
5 use disorder prescribed according to generally accepted national profes-
6 sional guidelines for the treatment of a substance use disorder. Such
7 medication assisted treatment shall not be subject to any prior authori-
8 zation mandate.
9 § 2. Subdivision 26-b of section 364-j of the social services law, as
10 added by section 4 of part B of chapter 69 of the laws of 2016, is
11 amended to read as follows:
12 26-b. Managed care providers shall not require prior authorization for
13 [an initial or renewal prescription for buprenorphine or injectable
14 naltrexone for detoxification or maintenance treatment of opioid
15 addiction unless the prescription is for a non-preferred or non-formu-
16 lary form of the drug or as otherwise required by section 1927(k)(6) of
17 the Social Security Act] any buprenorphine products, methadone or long
18 acting injectable naltrexone for detoxification or maintenance treatment
19 of a substance use disorder prescribed according to generally accepted
20 national professional guidelines for the treatment of a substance use
21 disorder.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD10713-05-9
A. 7246--B 2
1 § 3. Subdivision 10 of section 273 of the public health law, as added
2 by section 5 of part B of chapter 69 of the laws of 2016, is amended to
3 read as follows:
4 10. Prior authorization shall not be required for [an initial or
5 renewal prescription for buprenorphine or injectable naltrexone for
6 detoxification or maintenance treatment of opioid addiction unless the
7 prescription is for a non-preferred or non-formulary form of such drug
8 as otherwise required by section 1927(k)(6) of the Social Security Act]
9 any buprenorphine products, methadone or long acting injectable naltrex-
10 one for detoxification or maintenance treatment of a substance use
11 disorder prescribed according to generally accepted national profes-
12 sional guidelines for the treatment of a substance use disorder.
13 § 4. This act shall take effect on the ninetieth day after it shall
14 have become a law; provided, however, that the amendments to subdivision
15 26-b of section 364-j of the social services law made by section two of
16 this act shall not affect the repeal of such section, and shall be
17 deemed repealed therewith.
